Details

NameSymbolSector
CORAL LABORATORIES LTD.CORALABPharmaceuticals
Open
526
High
530
Low
486.5
Close
496.5
Volume
14222
Exchange
bse
Time
14/08

Outlook

Score:  

0

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Coral Laboratories is  
None
Estimated Stoploss of Coral Laboratories is ₹  
530
Coral Laboratories has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Coral Laboratories is  
Unpredictableℹ
. 

Trend

Coral Laboratories is in  
Strong Downtrendℹ
. 
Price of Coral Laboratories is  
Downℹ
 by  

14.92

%. 
Target
Buy @ 

486.5

Sell @ 

594.85

Volume

The trades of Coral Laboratories have been in  
Immenseℹ
 volume. 
The volume trades for Coral Laboratories are  
Bearishℹ
 with  
Strong Sellersℹ
The trade volume of Coral Laboratories is  

Up

 by  

900.43

% 

Valuation

The current market price of Coral Laboratories is  
Undervaluedℹ

Financials

Balance
The balance sheet of Coral Laboratories is:  

Balanced

Cashflow
Coral Laboratories has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 1cr

. It is  
Upℹ
 by  

125

%. 

(*Mar 2025)

33.33% i.e. ₹ 1cr spent in operatingℹ
0% in investingℹ
66.67% i.e. ₹ 2cr earned in financingℹ
0% in otherℹ
Coral Laboratories has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 4cr

. It is  
Downℹ
 by  

233.33

%. 

(*Mar 2024)

83.33% i.e. ₹ 5cr spent in operatingℹ
16.67% i.e. ₹ 1cr earned in investingℹ
0% in financingℹ
0% in otherℹ
Income
The income of Coral Laboratories is  

₹ 20cr

 and  

Profit

 is :  

₹ 2cr

(*Jun 2025)

Coral Laboratories Profit is up by:  

0

% and Income is Down by:  

33.33

% 

(*Jun 2025)

The income of Coral Laboratories is  

₹ 30cr

 and  

Profit

 is :  

₹ 2cr

(*Mar 2025)

Coral Laboratories Profit is down by:  

66.67

% and Income is Up by:  

20

% 

(*Mar 2025)

The income of Coral Laboratories is  

₹ 25cr

 and  

Profit

 is :  

₹ 6cr

(*Dec 2024)

Coral Laboratories Profit is up by:  

0

% and Income is Down by:  

26.47

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.